In parallel, it has been observed a down-regulation of the catabolic enzyme ADA and its cofactor CD26 (also known as dipeptidyl peptidase 4) [88,89,90] as well as the reduction of adenosine kinase activity [91] in the cancer microenvironment. Here, ADA is linked to cancer.